Skip to content
Insider tapeFilings through Fri, Nov 20
My stocks

West Pharmaceutical Services (WST) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareWST

Closing price · Nov 20, 2026 $390.30 -1.6% on the day · +51.8% over 12 months 52-week range $230.63 – $417.80
Get WST alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling2last 12 months
Reported sales$6.6M3 of 8 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 4, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Annette F. Favorite, Sr. Vp & Chief Hr Officer sold 2,524 shares at $365.00 ($921K).

Trade date
Sep 15, 2026
Disclosed to the SEC
Sep 15, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All WST insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

WST insider transactions (Form 4)

Open-market purchases and sales. 48 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Sep 15SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell Plan 2,52421,818 held (−10%) $365.00 $921K +6.9% —
Sep 15SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell Plan 2,50021,818 held (−10%) $355.00 $888K +9.9% —
Sep 15SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell Plan 2,50021,818 held (−10%) $345.00 $862K +13.1% —
Sep 10SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell 2,81816,845 held (−14%) $340.81 $960K +14.5% —
Sep 10SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell 2,81716,845 held (−14%) $340.81 $960K +14.5% —
Sep 10SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell 2,50016,845 held (−13%) $340.81 $852K +14.5% —
Apr 29SEC Annette F. FavoriteSr. Vp & Chief Hr Officer Sell 2,81716,828 held (−14%) $305.20 $860K +27.9% —
Apr 29SEC Chad WintersVp, Chief Accounting Officer Sell 8961,523 held (−37%) $300.67 $269K +29.8% —
Historical context

Similar past setups: not applicable. WST has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with WST in the Research Lab

WST has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

WST closeInsider buyInsider sale
200300400500DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-12EEarnings release filed 2026-04-23EEarnings release filed 2026-07-23EEarnings release filed 2026-10-29Sold $862,500 on 2026-09-11 · Annette F. FavoriteSold $887,500 on 2026-09-14 · Annette F. FavoriteSold $921,260 on 2026-09-15 · Annette F. FavoriteSold $1,129,153 on 2026-04-27 · Annette F. Favorite, Chad WintersSold $2,772,489 on 2026-09-08 · Annette F. Favorite
Bought, 12 months$0
Sold, 12 months$6.6M
Insiders buying0
Insiders selling2

West Pharmaceutical Services insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $6.6M of WST stock on the open market; P/E 49.5 vs. a sector median of 24.5.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

WST insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $1.1M sold (2 trades)Q2 2026Q3 2026: $5.4M sold (6 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$5.4M6
Q2 2026—0$1.1M2

Valuation, profit and volume

P/E (trailing)49.5Sector median 24.5
Volume vs. 50-day0.9×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 West Pharmaceutical Services insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $6.6M. 3 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

WST earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 29, 2026 +8.6% None +2.2%S&P -2.1% pending
Jul 23, 2026 +0.7% None -8.4%S&P -1.1% +7.7%
Apr 23, 2026 +5.8% None +11.6%S&P +0.4% +3.4%
Feb 12, 2026 +2.4% None +1.8%S&P -1.5% -6.0%
Oct 23, 2025 +4.1% None +7.4%S&P +1.4% -8.8%
Jul 24, 2025 +3.1% None +15.9%S&P +0.5% -5.9%
Apr 24, 2025 +14.6% None -1.7%S&P +2.8% -4.1%
Feb 13, 2025 -6.1% None -33.4%S&P +1.1% +7.2%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

WST short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-28: 59% of volume sold short2026-08-31: 68% of volume sold short2026-09-01: 68% of volume sold short2026-09-02: 64% of volume sold short2026-09-03: 66% of volume sold short2026-09-04: 39% of volume sold short2026-09-08: 39% of volume sold short2026-09-09: 58% of volume sold short2026-09-10: 66% of volume sold short2026-09-11: 56% of volume sold short2026-09-14: 64% of volume sold short2026-09-15: 55% of volume sold short2026-09-16: 50% of volume sold short2026-09-17: 68% of volume sold short2026-09-18: 72% of volume sold short2026-09-21: 54% of volume sold short2026-09-22: 50% of volume sold short2026-09-23: 32% of volume sold short2026-09-24: 35% of volume sold short2026-09-25: 48% of volume sold short2026-09-28: 32% of volume sold short2026-09-29: 53% of volume sold short2026-09-30: 42% of volume sold short2026-10-01: 51% of volume sold short2026-10-02: 67% of volume sold short2026-10-05: 40% of volume sold short2026-10-06: 57% of volume sold short2026-10-07: 77% of volume sold short2026-10-08: 58% of volume sold short2026-10-09: 50% of volume sold short2026-10-12: 65% of volume sold short2026-10-13: 61% of volume sold short2026-10-14: 52% of volume sold short2026-10-15: 63% of volume sold short2026-10-16: 54% of volume sold short2026-10-19: 66% of volume sold short2026-10-20: 61% of volume sold short2026-10-21: 63% of volume sold short2026-10-22: 53% of volume sold short2026-10-23: 41% of volume sold short2026-10-26: 40% of volume sold short2026-10-27: 49% of volume sold short2026-10-28: 63% of volume sold short2026-10-29: 47% of volume sold short2026-10-30: 46% of volume sold short2026-11-02: 21% of volume sold short2026-11-03: 30% of volume sold short2026-11-04: 25% of volume sold short2026-11-05: 24% of volume sold short2026-11-06: 49% of volume sold short2026-11-09: 40% of volume sold short2026-11-10: 53% of volume sold short2026-11-11: 49% of volume sold short2026-11-12: 74% of volume sold short2026-11-13: 54% of volume sold short2026-11-16: 51% of volume sold short2026-11-17: 43% of volume sold short2026-11-18: 53% of volume sold short2026-11-19: 36% of volume sold short2026-11-20: 48% of volume sold shortAug 28Sep 14Sep 28Oct 12Oct 26Nov 9
Latest (Nov 20): 48%20-day average: 41%Prior 2 months: 54%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Insiders at West Pharmaceutical Services

InsiderBoughtSoldLast filingPast buys beat S&PScore
Annette F. FavoriteSr. Vp & Chief Hr Officer — $6.3M Sep 15, 2026 — —
Chad WintersVp, Chief Accounting Officer — $269K Apr 29, 2026 — —
Robert W. McMahonCFO — — Aug 12, 2026 — —
Shane Alden CampbellSvp, Proprietary Segment — — May 14, 2026 — —
Mark A. ButhmanDirector — — May 6, 2026 — —
William F. FeeheryDirector — — May 6, 2026 0 of 1 —
Robert F. FrielDirector — — May 6, 2026 — —
Janet Brutschea HaugenDirector — — May 6, 2026 — —
Molly JosephDirector — — May 6, 2026 — —
Deborah L. KellerDirector — — May 6, 2026 — —
Goldman Myla LaiDirector — — May 6, 2026 — —
Stephen H. LockhartDirector — — May 6, 2026 — —
Douglas A. MichelsDirector — — May 6, 2026 — —
Paolo PucciDirector — — May 6, 2026 — —
Rodolphe Jean PoussotSvp, Strategy & Corporate Dev — — Feb 23, 2026 — —
Charles WitherspoonVp & Treasurer — — Feb 23, 2026 — —
Eric Mark GreenCEO, President — — Feb 19, 2026 — —

Board links: companies that share insiders with WST

Directors and executives who filed Form 4s for WST and another company in the last 12 months.

See the map →
  • CERTCertara William F. Feehery Director here · CEO at CERT · latest filing May 6, 2026
  • ECLEcolab Eric Mark Green CEO, President here · Director at ECL · latest filing Oct 2, 2026
  • IEXIDEX Mark A. Buthman Director here · Director at IEX · latest filing May 8, 2026
  • XYLXylem Robert F. Friel Director here · Director at XYL · latest filing May 15, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

WST stock: common questions

Are West Pharmaceutical Services insiders buying WST stock?

No. No West Pharmaceutical Services insider reported an open-market purchase of WST in the past 12 months.

Are West Pharmaceutical Services insiders selling WST stock?

2 insiders reported sales worth $6.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is WST's P/E ratio?

WST trades at about 49.5 times trailing earnings, compared with a median of 24.5 for the Health Care sector.

What is WST's 52-week range?

Over the past year WST has traded between $230.63 and $417.80. It last closed at $390.30 on Nov 20, 2026.